MedTrace Logo

Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

NCT05416983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2025-10-30

No results posted yet for this study

Summary

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

Conditions

  • Lung Non-Small Cell Carcinoma

Interventions

PROCEDURE

Discussion

Attend discussion

OTHER

Questionnaire Administration

Complete questionnaire

Sponsors & Collaborators

Principal Investigators

  • Konstantinos Leventakos, M.D. · Mayo Clinic in Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-17
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416983 on ClinicalTrials.gov